Your browser doesn't support javascript.
loading
Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer.
Vargas, Carlos E; Alam, Now Bahar; Terk, Mitchell; Niska, Joshua R; Cesaretti, Jamie; Swartz, Douglas; Vashi, Apoorva; Kasraeian, Ali; West, C Shawn; Blasser, Marc; Moore, Chris.
Afiliação
  • Vargas CE; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA. Electronic address: vargas.carlos@mayo.edu.
  • Alam NB; Maricopa Medical Center, Phoenix, AZ, USA.
  • Terk M; Florida Physician Specialists, Jacksonville, FL, USA.
  • Niska JR; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Cesaretti J; Florida Physician Specialists, Jacksonville, FL, USA.
  • Swartz D; Florida Physician Specialists, Jacksonville, FL, USA.
  • Vashi A; Florida Physician Specialists, Jacksonville, FL, USA.
  • Kasraeian A; Florida Physician Specialists, Jacksonville, FL, USA.
  • West CS; Florida Physician Specialists, Jacksonville, FL, USA.
  • Blasser M; Florida Physician Specialists, Jacksonville, FL, USA.
  • Moore C; Florida Physician Specialists, Jacksonville, FL, USA.
Cancer Treat Res Commun ; 19: 100119, 2019.
Article em En | MEDLINE | ID: mdl-30772671

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Qualidade de Vida / Braquiterapia / Quimiorradioterapia / Radioterapia Guiada por Imagem / Antagonistas de Androgênios Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Qualidade de Vida / Braquiterapia / Quimiorradioterapia / Radioterapia Guiada por Imagem / Antagonistas de Androgênios Idioma: En Ano de publicação: 2019 Tipo de documento: Article